220 related articles for article (PubMed ID: 12207645)
21. Pharmacogenomics and personalized medicine: mapping of future value creation.
Hu SX; Foster T; Kieffaber A
Biotechniques; 2005 Oct; 39(10 Suppl):S1-6. PubMed ID: 18957035
[No Abstract] [Full Text] [Related]
22. Pharmacogenetic Markers of Drug Efficacy and Toxicity.
Yip VL; Hawcutt DB; Pirmohamed M
Clin Pharmacol Ther; 2015 Jul; 98(1):61-70. PubMed ID: 25870137
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics and drug metabolism.
Ball S; Borman N
Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033
[No Abstract] [Full Text] [Related]
24. Drug evaluation, drug development and pharmacogenetics: celebrating 30 years of progress.
Li Wan Po A
J Clin Pharm Ther; 2005 Feb; 30(1):1-4. PubMed ID: 15658998
[No Abstract] [Full Text] [Related]
25. Understanding the Pathogenesis, Therapeutic Targets/Drug Action and Pharmacogenetics of Type 2 Diabetes: Is there a Future for Personalised Medicine?
Engwa GA; Nweke FN; Karngong GN; Afiukwa CA; Nwagu KE
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1569-1589. PubMed ID: 32334506
[TBL] [Abstract][Full Text] [Related]
26. [Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects].
Allorge D; Beaune PH; Becquemont L; Bessard G; Bezieau S; Boisdron-Celle M; Boyer JC; Broly F; Dhaneens CM; Fonrose X; Gagnieu MC; Gamelin E; Gozé C; Jacqz-Aigrain E; Loric S; Loriot MA; Marquet P; Morel A; Namour B; Paintaud G; Peoc'h K; Picard N; Watier H; Verstuyft C
Ann Pharm Fr; 2007 Nov; 65(6):371-81. PubMed ID: 18079669
[TBL] [Abstract][Full Text] [Related]
27. Current progress in pharmacogenetics.
Blakey JD; Hall IP
Br J Clin Pharmacol; 2011 Jun; 71(6):824-31. PubMed ID: 21235621
[TBL] [Abstract][Full Text] [Related]
28. Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine.
Frueh FW
Pharmacogenomics; 2009 Jul; 10(7):1077-81. PubMed ID: 19604080
[TBL] [Abstract][Full Text] [Related]
29. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
Lesko LJ; Zineh I
Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics: improving drug and dose selection.
Bhathena A; Spear BB
Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacogenetics in future medical care -- implications for patients and physicians].
Rogausch A; Brockmöller J; Himmel W
Gesundheitswesen; 2005 Apr; 67(4):257-63. PubMed ID: 15856385
[TBL] [Abstract][Full Text] [Related]
32. Individualization of drug therapy: history, present state, and opportunities for the future.
Lesko LJ; Schmidt S
Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891
[TBL] [Abstract][Full Text] [Related]
33. Overview of pharmacogenetics.
Katz DA; Bhathena A
Curr Protoc Hum Genet; 2009 Jan; Chapter 9():Unit 9.19. PubMed ID: 19170034
[TBL] [Abstract][Full Text] [Related]
34. Genetic diversity and new therapeutic concepts.
Shastry BS
J Hum Genet; 2005; 50(7):321-328. PubMed ID: 16041496
[TBL] [Abstract][Full Text] [Related]
35. The emerging role of electronic medical records in pharmacogenomics.
Wilke RA; Xu H; Denny JC; Roden DM; Krauss RM; McCarty CA; Davis RL; Skaar T; Lamba J; Savova G
Clin Pharmacol Ther; 2011 Mar; 89(3):379-86. PubMed ID: 21248726
[TBL] [Abstract][Full Text] [Related]
36. Smoking cessation treatment: pharmacogenetic assessment.
Munafò MR; Lerman C; Niaura R; Shields AE; Swan GE
Curr Opin Mol Ther; 2005 Jun; 7(3):202-8. PubMed ID: 15977416
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics: past, present and future.
Pirmohamed M
Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816
[TBL] [Abstract][Full Text] [Related]
38. Personalized medicine: revolutionizing drug discovery and patient care.
Ginsburg GS; McCarthy JJ
Trends Biotechnol; 2001 Dec; 19(12):491-6. PubMed ID: 11711191
[TBL] [Abstract][Full Text] [Related]
39. The potential of a placebo/nocebo effect in pharmacogenetics.
Haga SB; Warner LR; O'Daniel J
Public Health Genomics; 2009; 12(3):158-62. PubMed ID: 19204418
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics: the Dx perspective.
Cartwright CP
Expert Rev Mol Diagn; 2001 Nov; 1(4):371-6. PubMed ID: 11901851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
